3 THINGS TO KNOW IN #MIAMITECH: $19M FUNDING ROUND, ENDEAVOR SCALEUP OPENS APPLICATIONS, MORE

    0
    113
    1 Exuma Biotech raises $19 million in funding

    Exuma Biotech, formerly known as F1 Oncology, announced it has raised $19 million in Series B financing.

    The West Palm Beach-based  clinical-stage biotechnology company discovering and developing immunotherapies for solid and liquid tumors, will use the funds to advance its CAR-T therapies for solid tumor malignancies as well as further developing its platform technology in the field of oncology.